PROM1 and endometrial cancer: In contrast, expression of SOX2 and NANOG was significantly lower in CD133+ve cells compared with CD133-ve cells (Figure 2a), consistent with earlier findings that ALDH activity may be a better marker of endometrial cancer stem cell activity.